154 related articles for article (PubMed ID: 34799214)
1. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
2. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease.
Tokuda K; Tanaka A; Tobe A; Shirai Y; Kurobe M; Kubota Y; Kunieda T; Miyazaki T; Mizutani K; Furusawa K; Ishii H; Murohara T
J Atheroscler Thromb; 2023 Nov; 30(11):1635-1643. PubMed ID: 36908149
[TBL] [Abstract][Full Text] [Related]
3. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
Takahashi N; Dohi T; Endo H; Funamizu T; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268533
[TBL] [Abstract][Full Text] [Related]
4. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
Jones D; Spirito A; Sartori S; Smith KF; Pivato CA; Chiarito M; Cao D; Nicolas J; Beerkens F; Edens M; Pileggi B; Sen A; Zhang Z; Vogel B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
J Cardiol; 2023 Sep; 82(3):179-185. PubMed ID: 37187289
[TBL] [Abstract][Full Text] [Related]
6. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
[TBL] [Abstract][Full Text] [Related]
7. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
8. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.
Ahn JH; Tantry US; Kang MG; Park HW; Koh JS; Bae JS; Cho SY; Kim KH; Jang JY; Park JR; Park Y; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
JACC Asia; 2022 Jun; 2(3):323-337. PubMed ID: 36338415
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
[TBL] [Abstract][Full Text] [Related]
10. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
Takeuchi M; Dohi T; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
Heart Vessels; 2021 Aug; 36(8):1117-1124. PubMed ID: 33606067
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
12. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
[TBL] [Abstract][Full Text] [Related]
13. Impact of preprocedural high-sensitive C-reactive protein levels on long-term clinical outcomes of patients with stable coronary artery disease and chronic kidney disease who were treated with drug-eluting stents.
Ogita M; Miyauchi K; Kasai T; Doi S; Wada H; Naito R; Konishi H; Tsuboi S; Dohi T; Tamura H; Okazaki S; Daida H
J Cardiol; 2015 Jul; 66(1):15-21. PubMed ID: 25572020
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry.
Miyazaki T; Ashikaga T; Asano M; Sasaoka T; Kurihara K; Yoshikawa S; Isobe M;
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E9-E16. PubMed ID: 30714680
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
16. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis.
Jonas M; Kagan M; Sella G; Haberman D; Chernin G
BMC Nephrol; 2020 Oct; 21(1):445. PubMed ID: 33097001
[TBL] [Abstract][Full Text] [Related]
18. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: Involvement of coronary plaque composition.
Kunimura A; Amano T; Uetani T; Harada K; Yoshida T; Suzuki A; Shimbo Y; Kitagawa K; Harada K; Kato B; Kato M; Takashima H; Ando H; Matsubara T; Ishii H; Murohara T
J Cardiol; 2013 Mar; 61(3):189-95. PubMed ID: 23182943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
